154 related articles for article (PubMed ID: 32843651)
1. Genomic profiling of the transcription factor Zfp148 and its impact on the p53 pathway.
Zou ZV; Gul N; Lindberg M; Bokhari AA; Eklund EM; Garellick V; Patel AAH; Dzanan JJ; Titmuss BO; Le Gal K; Johansson I; Tivesten Å; Forssell-Aronsson E; Bergö MO; Staffas A; Larsson E; Sayin VI; Lindahl P
Sci Rep; 2020 Aug; 10(1):14156. PubMed ID: 32843651
[TBL] [Abstract][Full Text] [Related]
2. Loss of one copy of Zfp148 reduces lesional macrophage proliferation and atherosclerosis in mice by activating p53.
Sayin VI; Khan OM; Pehlivanoglu LE; Staffas A; Ibrahim MX; Asplund A; Agren P; Nilton A; Bergström G; Bergo MO; Borén J; Lindahl P
Circ Res; 2014 Oct; 115(9):781-9. PubMed ID: 25212213
[TBL] [Abstract][Full Text] [Related]
3. E2F transcriptional repressor complexes are critical downstream targets of p19(ARF)/p53-induced proliferative arrest.
Rowland BD; Denissov SG; Douma S; Stunnenberg HG; Bernards R; Peeper DS
Cancer Cell; 2002 Jul; 2(1):55-65. PubMed ID: 12150825
[TBL] [Abstract][Full Text] [Related]
4. p14(ARF) regulates E2F activity.
Mason SL; Loughran O; La Thangue NB
Oncogene; 2002 Jun; 21(27):4220-30. PubMed ID: 12082609
[TBL] [Abstract][Full Text] [Related]
5. Zfp148 deficiency causes lung maturation defects and lethality in newborn mice that are rescued by deletion of p53 or antioxidant treatment.
Sayin VI; Nilton A; Ibrahim MX; Ågren P; Larsson E; Petit MM; Hultén LM; Ståhlman M; Johansson BR; Bergo MO; Lindahl P
PLoS One; 2013; 8(2):e55720. PubMed ID: 23405202
[TBL] [Abstract][Full Text] [Related]
6. Repression of the Arf tumor suppressor by E2F3 is required for normal cell cycle kinetics.
Aslanian A; Iaquinta PJ; Verona R; Lees JA
Genes Dev; 2004 Jun; 18(12):1413-22. PubMed ID: 15175242
[TBL] [Abstract][Full Text] [Related]
7. Ablation of endothelial
Yao H; Li J; Liu Z; Ouyang C; Qiu Y; Zheng X; Mu J; Xie Z
Autophagy; 2023 May; 19(5):1491-1511. PubMed ID: 36300763
[TBL] [Abstract][Full Text] [Related]
8. Targeting Zfp148 activates p53 and reduces tumor initiation in the gut.
Nilton A; Sayin VI; Zou ZV; Sayin SI; Bondjers C; Gul N; Agren P; Fogelstrand P; Nilsson O; Bergo MO; Lindahl P
Oncotarget; 2016 Aug; 7(35):56183-56192. PubMed ID: 27487143
[TBL] [Abstract][Full Text] [Related]
9. Deregulated beta-catenin induces a p53- and ARF-dependent growth arrest and cooperates with Ras in transformation.
Damalas A; Kahan S; Shtutman M; Ben-Ze'ev A; Oren M
EMBO J; 2001 Sep; 20(17):4912-22. PubMed ID: 11532955
[TBL] [Abstract][Full Text] [Related]
10. C/EBPbeta cooperates with RB:E2F to implement Ras(V12)-induced cellular senescence.
Sebastian T; Malik R; Thomas S; Sage J; Johnson PF
EMBO J; 2005 Sep; 24(18):3301-12. PubMed ID: 16107878
[TBL] [Abstract][Full Text] [Related]
11. ARF directly binds DP1: interaction with DP1 coincides with the G1 arrest function of ARF.
Datta A; Sen J; Hagen J; Korgaonkar CK; Caffrey M; Quelle DE; Hughes DE; Ackerson TJ; Costa RH; Raychaudhuri P
Mol Cell Biol; 2005 Sep; 25(18):8024-36. PubMed ID: 16135794
[TBL] [Abstract][Full Text] [Related]
12. p19(ARF) is dispensable for oncogenic stress-induced p53-mediated apoptosis and tumor suppression in vivo.
Tolbert D; Lu X; Yin C; Tantama M; Van Dyke T
Mol Cell Biol; 2002 Jan; 22(1):370-7. PubMed ID: 11739748
[TBL] [Abstract][Full Text] [Related]
13. Loss of p19(ARF) eliminates the requirement for the pRB-binding motif in simian virus 40 large T antigen-mediated transformation.
Chao HH; Buchmann AM; DeCaprio JA
Mol Cell Biol; 2000 Oct; 20(20):7624-33. PubMed ID: 11003658
[TBL] [Abstract][Full Text] [Related]
14. Activation of ARF by oncogenic stress in mouse fibroblasts is independent of E2F1 and E2F2.
Palmero I; Murga M; Zubiaga A; Serrano M
Oncogene; 2002 May; 21(19):2939-47. PubMed ID: 12082524
[TBL] [Abstract][Full Text] [Related]
15. Depletion of ERK2 but not ERK1 abrogates oncogenic Ras-induced senescence.
Shin J; Yang J; Lee JC; Baek KH
Cell Signal; 2013 Dec; 25(12):2540-7. PubMed ID: 23993963
[TBL] [Abstract][Full Text] [Related]
16. p19(Arf) is required for the cellular response to chronic DNA damage.
Bieging-Rolett KT; Johnson TM; Brady CA; Beaudry VG; Pathak N; Han S; Attardi LD
Oncogene; 2016 Aug; 35(33):4414-21. PubMed ID: 26725325
[TBL] [Abstract][Full Text] [Related]
17. [Molecular mechanisms controlling the cell cycle: fundamental aspects and implications for oncology].
Viallard JF; Lacombe F; Belloc F; Pellegrin JL; Reiffers J
Cancer Radiother; 2001 Apr; 5(2):109-29. PubMed ID: 11355576
[TBL] [Abstract][Full Text] [Related]
18. Early growth response 1 protein, an upstream gatekeeper of the p53 tumor suppressor, controls replicative senescence.
Krones-Herzig A; Adamson E; Mercola D
Proc Natl Acad Sci U S A; 2003 Mar; 100(6):3233-8. PubMed ID: 12629205
[TBL] [Abstract][Full Text] [Related]
19. p53-dependent down-regulation of telomerase is mediated by p21waf1.
Shats I; Milyavsky M; Tang X; Stambolsky P; Erez N; Brosh R; Kogan I; Braunstein I; Tzukerman M; Ginsberg D; Rotter V
J Biol Chem; 2004 Dec; 279(49):50976-85. PubMed ID: 15371422
[TBL] [Abstract][Full Text] [Related]
20. The promoters of human cell cycle genes integrate signals from two tumor suppressive pathways during cellular transformation.
Tabach Y; Milyavsky M; Shats I; Brosh R; Zuk O; Yitzhaky A; Mantovani R; Domany E; Rotter V; Pilpel Y
Mol Syst Biol; 2005; 1():2005.0022. PubMed ID: 16729057
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
